Head and Neck CancerNCT05915572
Mulligan Technique on Shoulder Dysfunction
A study testing Mulligan Mobilization Technique and Traditional Physical Therapy Program in people with Head and Neck Cancer, run by Cairo University at 1 site in Egypt.
Trial summary
76 patients suffering from shoulder dysfunction following neck dissection surgeries will participate in this study. The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups. Read more about this study
- Who is it for?
- Ages 30 to 50 years
- Conditions the study is for
- Head and Neck Cancer
- What is being tested?
- Mulligan Mobilization Technique and Traditional Physical Therapy Program
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 76 participants
- Where
- 1 siteEgypt
- Study dates
- 1 Jul 2023to 1 Apr 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 30 to 50 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Patients' age will be between 30-50 years old.
- Both gender 76 patients will participate in this study.
Who cannot join
- Patients with rotator cuff tears and other shoulder ligament injuries or tendon calcification.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of Mulligan Technique on Shoulder Dysfunction Post Neck Dissection Surgeries
76 patients suffering from shoulder dysfunction following neck dissection surgeries will participate in this study. The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups.
Group (A): 38 patients will receive MWM in plus traditional physiotherapy program 3 sessions per week for 6 weeks.
Group (B): 38 patients will receive traditional physiotherapy program 3 sessions per week for 6 weeks.
Read the detailed description
- Subjects: 76 patients suffering from shoulder dysfunction following neck dissection surgeries will participate in this study. The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups.
Group (A): 38 patients will receive MWM in plus traditional physiotherapy program 3 sessions per week for 6 weeks.
Group (B): 38 patients will receive traditional physiotherapy program 3 sessions per week for 6 weeks.
The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups equal in number.
- Equipment:
Therapeutic equipment:
- Mulligan Mobilization Technique: to increase shoulder flexion, abduction, external rotation
- Traditional physical therapy program:
Measurement equipment:
- Digital Goniometer
- Shoulder Pain and Disability Index
- Conditions
- Head and Neck Cancer
- Being tested
- Mulligan Mobilization Technique, Traditional Physical Therapy Program
- Keywords
- Mulligan Technique, Shoulder Dysfunction, Neck Dissection Surgeries
- Medical subject headings
- Head and Neck Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mulligan Mobilization TechniqueOther
The therapist applied passive accessory glide to increase shoulder flexion, abduction, external rotation
Traditional Physical Therapy ProgramOther
Myofascial release and ROM ex. 3 sessions per week for 6 weeks.
| Study group | Role | What they receive |
|---|---|---|
| Mulligan Mobilization Technique Plus Traditional Physical Therapy Program | Experimental | Mulligan Mobilization Technique plus traditional physical therapy program 3 sessions per week for 6 weeks. Receives: Other: Mulligan Mobilization Technique; Other: Traditional Physical Therapy Program |
| Traditional Physical Therapy Program | Experimental | Traditional physical therapy program 3 sessions per week for 6 weeks Receives: Other: Traditional Physical Therapy Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Digital Goniometer
Measure shoulder ROM
Measured: 6 weeks
Secondary outcomes (1)
Shoulder Pain and Disability Index
Measure pain and disability
Measured: 6 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jun 2023
- Study start1 Jul 2023
- Primary completion1 Mar 2024
- Study completion1 Apr 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Head and Neck CancerStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 76 participants (actual)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mona Mohamed Amin Ziethar, Cairo University
- Investigators
- Research Ethical Committee Faculty of Physical Therapy, Principal investigator, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05915572
- Sponsor's protocol ID
- 752015
- Status last verified
- Jun 2024
- First submitted
- 14 Jun 2023
- Last updated
- 3 Jul 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Mulligan Technique on Shoulder Dysfunction Post Neck Dissection Surgeries
- ClinicalTrials.gov ID
- NCT05915572
- Acronym / sponsor ID
- 752015
- Conditions
- Head and Neck Cancer
- Keywords
- Mulligan Technique, Shoulder Dysfunction, Neck Dissection Surgeries
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 76 participants (actual)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 1 Jul 2023 (actual)
- Primary completion
- 1 Mar 2024 (actual)
- Study completion
- 1 Apr 2024 (actual)
- First posted
- 23 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
76 patients suffering from shoulder dysfunction following neck dissection surgeries will participate in this study. The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups.
Group (A): 38 patients will receive MWM in plus traditional physiotherapy program 3 sessions per week for 6 weeks.
Group (B): 38 patients will receive traditional physiotherapy program 3 sessions per week for 6 weeks.
Detailed description
- Subjects: 76 patients suffering from shoulder dysfunction following neck dissection surgeries will participate in this study. The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups.
Group (A): 38 patients will receive MWM in plus traditional physiotherapy program 3 sessions per week for 6 weeks.
Group (B): 38 patients will receive traditional physiotherapy program 3 sessions per week for 6 weeks.
The participants will be selected from Damanhur Oncology Center and randomly will be distributed into two groups equal in number.
- Equipment:
Therapeutic equipment:
- Mulligan Mobilization Technique: to increase shoulder flexion, abduction, external rotation
- Traditional physical therapy program:
Measurement equipment:
- Digital Goniometer
- Shoulder Pain and Disability Index
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mulligan Mobilization Technique Plus Traditional Physical Therapy Program | Experimental | Other: Mulligan Mobilization Technique, Other: Traditional Physical Therapy ProgramMulligan Mobilization Technique plus traditional physical therapy program 3 sessions per week for 6 weeks. |
| Traditional Physical Therapy Program | Experimental | Other: Traditional Physical Therapy ProgramTraditional physical therapy program 3 sessions per week for 6 weeks |
Who may qualify
- Ages
- 30 to 50 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Patients' age will be between 30-50 years old.
- Both gender 76 patients will participate in this study.
Key exclusion criteria (1 listed)
- Patients with rotator cuff tears and other shoulder ligament injuries or tendon calcification.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mulligan Mobilization TechniqueThe therapist applied passive accessory glide to increase shoulder flexion, abduction, external rotation | Other | Mulligan Mobilization Technique Plus Traditional Physical Therapy Program |
| Traditional Physical Therapy ProgramMyofascial release and ROM ex. 3 sessions per week for 6 weeks. | Other | Mulligan Mobilization Technique Plus Traditional Physical Therapy Program, Traditional Physical Therapy Program |
Primary outcome
Digital Goniometer
Time frame: 6 weeks
Measure shoulder ROM
1 secondary outcome
Shoulder Pain and Disability Index
Time frame: 6 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jul 2024.
Related trials for Head and Neck Cancer
RecruitingPhase 3
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally Advanced Laryngeal Squamous Cell Carcinoma
Active, not recruitingPhase 2
Olaparib in Combination With Pembrolizumab and Carboplatin as First-Line Treatment of Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma
Not yet recruitingPhase 1/2
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
Thyroid Cancer
Enrolling by invitationObservational study
Parathyroid Adenoma Detection With Rubidium-82 Imaging
Parathyroid Adenomas, Hyperparathyroidism, Primary
RecruitingPhase 3
Flap Sparing in Postoperative Radiotherapy of Oral Cavity Cancers
Oral Cavity Carcinoma, Flap
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Research Ethical Committee Faculty of Physical Therapy principal investigator
Cairo University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mulligan Mobilization Technique and Traditional Physical Therapy Program in people with Head and Neck Cancer, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Digital Goniometer (time frame: 6 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jul 2024.